TL;DR
Get everyday helpers delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
MedPage Today’s Oct. 25, 2026, roundup collected seven comments from clinicians and researchers on recent health stories. The topics ranged from dengue outbreaks and a multiple sclerosis misdiagnosis to early research on menopause treatments and psilocybin; the roundup does not establish new clinical findings or guidance.
MedPage Today published a weekly collection of seven health-related comments on October 25, 2026, covering dengue outbreaks, pregnancy exposure to an eczema drug, menopause treatments, a rare diagnostic case and early research. The roundup records what clinicians and researchers said about those stories; it is not itself a new study or a clinical guideline.
Among the comments was a warning from Adam Waickman, a researcher at SUNY Upstate Medical University, about dengue outbreaks in Florida and the possibility of further spread in the United States. “The cat is out of the bag,” he said. The roundup provides no outbreak figures, locations beyond Florida, or timetable for any potential spread.
Christina Chambers of the University of California San Diego described a separate research question: whether early-life exposure to dupilumab, sold as Dupixent, might affect children’s long-term risk of atopic conditions. She said exposure during pregnancy appeared safe in the data discussed, but called the possible longer-term effect “an open question.” The roundup does not provide study details or establish a long-term benefit.
Other entries address an incorrect multiple sclerosis diagnosis reported by actress Christina Applegate, an exceptionally rare infant case involving a second colon, a meta-analysis of non-hormonal menopause drugs and sleep disturbances, advance care planning for people nearing kidney failure, and a small trial of psilocybin in patients with Parkinson’s disease. The brief item offers no methods, sample sizes or detailed results for these underlying reports.
Seven Comments, Several Health Questions
The roundup brings several distinct clinical and research topics into one short report, while its quotes point to different levels of evidence. A reported outbreak, a meta-analysis and a small trial cannot be treated as equivalent findings. Readers should regard the statements as attributed commentary on the underlying coverage, not as a substitute for the original reporting or studies.
The distinction is particularly relevant for health claims that may affect expectations about prevention or treatment. The menopause item refers to a meta-analysis, while the Parkinson’s item concerns a small trial and biological markers. Neither the roundup nor the quoted wording supplies enough information to judge the size, reliability or practical importance of the reported effects.
dengue mosquito repellent EPA registered DEET
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
The Stories Behind the Quotes
The piece is a recurring “What We Heard” roundup published by MedPage Today. Its format collects brief quotations from people involved in or commenting on health stories, rather than presenting a single investigation. The October 25 edition spans infectious disease, maternal and child health, diagnosis, menopause, serious illness planning and experimental research.
Several quotes describe questions or concerns rather than settled conclusions. Chambers explicitly said the long-term consequences of early-life dupilumab exposure remain an open question. Ellen Bradley, discussing the psilocybin trial, said the findings raised biological questions for researchers to pursue; the quoted summary does not describe a proven treatment effect. The source provides no additional dates for the studies or events referenced.
““This is good news for women.””
— JoAnn Manson, MD, MPH, DrPH, Harvard Medical School
menopause sleep cooling pillow and breathable bedding
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Evidence and Details Still Missing
The roundup does not include the underlying papers, study designs, participant numbers, effect sizes or limitations for most of the research it mentions. It also does not quantify the dengue outbreaks or identify where further spread might occur. Those details would be needed to assess the strength and scope of the claims.
The quote about pregnancy exposure to dupilumab says the available data appeared safe, but does not specify the size or duration of the data set. The menopause and Parkinson’s comments likewise do not provide enough detail to determine how broadly their findings apply. The rare infant case and the multiple sclerosis diagnosis are summarized briefly, without a full clinical timeline.
advance care planning workbook medical decisions
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Check the Underlying Reports
The next step for readers seeking detail is to consult MedPage Today’s individual reports and the studies or clinical accounts behind them. Those materials can clarify the evidence, methods and limitations that a quote-based weekly roundup cannot provide. The October 25 item itself announces no follow-up date, policy change or new clinical recommendation.
pregnancy medication and health journal
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What did MedPage Today publish?
It published a seven-quote weekly roundup on October 25, 2026, covering a range of health stories and research topics.
Does the dengue quote confirm further spread in the United States?
No. Adam Waickman warned of possible further spread while discussing Florida outbreaks. The roundup provides no forecast or supporting outbreak data.
Did the roundup establish that dupilumab exposure benefits children?
No. Christina Chambers said the possible effect of early-life exposure on long-term atopic conditions remains an open question. The quoted pregnancy data appeared safe, but the roundup gives no study details.
What did the menopause research report?
The roundup says a meta-analysis found that non-hormonal menopause drugs can ease sleep disturbances. It does not identify the drugs, effect size or analysis methods.
Does the psilocybin trial show it treats Parkinson’s disease?
The roundup describes a small trial linking psilocybin with changes in markers of inflammation and mitochondrial stress. It does not establish a treatment benefit for Parkinson’s disease.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
